Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan

Published:2015-10 Issue: Volume: Page:505
ISSN:1178-6981
Container-title:ClinicoEconomics and Outcomes Research
language:en
Short-container-title:CEOR

Author:

Sadosky Alesia,Igarashi Ataru,Akazawa Manabu,Murata Tatsunori,Taguchi Toshihiko,Ebata Nozomi,Willke Richard,Fujii Koichi,Doherty Jim,Kobayashi Makoto

Publisher

Informa UK Limited

Subject

Health Policy,Economics, Econometrics and Finance (miscellaneous)

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of time length to Boolean remission for tight disease activity control after acquisition in rheumatoid arthritis patients;Scientific Reports;2023-08-25

2. Clinical Outcomes of Mirogabalin Treatment for Neuropathic Pain Due to Spinal Diseases in Patients Intolerant to Continuous Administration of Pregabalin;Spine Surgery and Related Research;2023-03-27

3. Associations between clinical metrics of joint deformity, disease duration, disease activity, functional capacity, quality of life, pain, and fatigue in patients with rheumatoid arthritis;Clinical Rheumatology;2022-11-12

4. Clinical characteristics and variants that predict prognosis of difficult-to-treat rheumatoid arthritis;Rheumatology International;2022-04-11

5. Associations of Cognitive Complaints and Depressive Symptoms with Health-Related Quality of Life and Perceived Overall Health in Japanese Adult Volunteers;International Journal of Environmental Research and Public Health;2021-09-13